Detalles de la búsqueda
1.
Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients.
Int J Mol Sci
; 24(13)2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446173
2.
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
J Inherit Metab Dis
; 43(4): 737-747, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609457
3.
Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
Biol Blood Marrow Transplant
; 22(1): 164-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26303102
4.
Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial.
Biol Blood Marrow Transplant
; 22(7): 1247-1256, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968792
5.
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
Ann Rheum Dis
; 75(2): 362-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25475116
6.
Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria.
JIMD Rep
; 63(1): 41-49, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028270
7.
Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index.
JIMD Rep
; 63(4): 361-370, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35822087
8.
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.
Metabolites
; 12(8)2022 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005644
9.
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria.
Metabolites
; 12(10)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295821
10.
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone.
RMD Open
; 8(2)2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36270742
11.
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies.
Transplant Cell Ther
; 27(10): 837.e1-837.e10, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224914
12.
Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortium.
Orphanet J Rare Dis
; 16(1): 510, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906169
13.
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.
Lancet Diabetes Endocrinol
; 9(7): 427-435, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023005
14.
A patient survey on the impact of alkaptonuria symptoms as perceived by the patients and their experiences of receiving diagnosis and care.
JIMD Rep
; 53(1): 71-79, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395411
15.
Inter-laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples.
JIMD Rep
; 53(1): 90-102, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395414
16.
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.
Lancet Diabetes Endocrinol
; 8(9): 762-772, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822600
17.
Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1.
JIMD Rep
; 38: 81-88, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28643275
18.
Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin.
J Clin Pharmacol
; 55(10): 1109-18, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25880826
Resultados
1 -
18
de 18
1
Próxima >
>>